Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

Reproductive outcomes of 105 malignant ovarian germ cell tumor survivors: a multicenter study.

Tamauchi S, Kajiyama H, Yoshihara M, Ikeda Y, Yoshikawa N, Nishino K, Utsumi F, Niimi K, Suzuki S, Kikkawa F.

Am J Obstet Gynecol. 2018 Oct;219(4):385.e1-385.e7. doi: 10.1016/j.ajog.2018.07.021. Epub 2018 Aug 4.

2.

Treatment of malignant ovarian germ cell tumors and preservation of fertility.

Zhang R, Sun YC, Zhang GY, Wu LY, Zuo J.

Eur J Gynaecol Oncol. 2012;33(5):489-92.

PMID:
23185794
3.

Analysis of outcomes and prognostic factors after fertility-sparing surgery in malignant ovarian germ cell tumors.

Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2017 Jun;145(3):513-518. doi: 10.1016/j.ygyno.2017.03.023. Epub 2017 Mar 31.

PMID:
28372870
4.

Giving Birth After Fertility Sparing Treatment of Embrional Carcinoma Figo III C: Case Report and Literature Review.

Cerovac A, Ljuca D, Nevacinovic E, Tulumovic A, Iljazovic E.

Med Arch. 2018 Nov;72(5):371-373. doi: 10.5455/medarh.2018.72.371-373. Review.

5.

Survival and reproductive function after treatment of malignant germ cell ovarian tumors.

Zanetta G, Bonazzi C, Cantù M, Binidagger S, Locatelli A, Bratina G, Mangioni C.

J Clin Oncol. 2001 Feb 15;19(4):1015-20.

PMID:
11181664
6.

[Multicenter randomized controlled clinical study for the operative treatment of malignant ovarian germ cell tumors].

Liu Q, Ding XL, Yang JX, Cao DY, Shen K, Lang JH, Zhang GN, Xin XY, Xie X, Zhang SL, Wu YM, Zhu GH, Wang J, Chen YL, Kong BH, Zheng JH.

Zhonghua Fu Chan Ke Za Zhi. 2013 Mar;48(3):188-92. Chinese.

PMID:
23849941
7.

Fertility-sparing surgery in advanced stage malignant ovarian germ cell tumor: a case report.

Ghalleb M, Bouzaiene H, Slim S, Hadiji A, Hechiche M, Ben Hassouna J, Rahal K.

J Med Case Rep. 2017 Dec 17;11(1):350. doi: 10.1186/s13256-017-1516-8.

8.

Outcomes of pediatric and adolescent girls with malignant ovarian germ cell tumors.

Park JY, Kim DY, Suh DS, Kim JH, Kim YM, Kim YT, Nam JH.

Gynecol Oncol. 2015 Jun;137(3):418-22. doi: 10.1016/j.ygyno.2015.03.054. Epub 2015 Apr 1.

PMID:
25842162
9.
10.

Reproductive function after treatment of ovarian germ cell malignancy.

Anita AN, Rushdan MN.

Med J Malaysia. 2012 Feb;67(1):71-6.

11.

Reproductive function after conservative surgery and chemotherapy for malignant germ cell tumors of the ovary.

Tangir J, Zelterman D, Ma W, Schwartz PE.

Obstet Gynecol. 2003 Feb;101(2):251-7.

PMID:
12576247
12.

Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors.

Weinberg LE, Lurain JR, Singh DK, Schink JC.

Gynecol Oncol. 2011 May 1;121(2):285-9. doi: 10.1016/j.ygyno.2011.01.003. Epub 2011 Jan 21.

PMID:
21256579
13.

Regional deep hyperthermia for salvage treatment of children and adolescents with refractory or recurrent non-testicular malignant germ-cell tumours: an open-label, non-randomised, single-institution, phase 2 study.

Wessalowski R, Schneider DT, Mils O, Friemann V, Kyrillopoulou O, Schaper J, Matuschek C, Rothe K, Leuschner I, Willers R, Schönberger S, Göbel U, Calaminus G; MAKEI study group.

Lancet Oncol. 2013 Aug;14(9):843-52. doi: 10.1016/S1470-2045(13)70271-7. Epub 2013 Jul 1.

PMID:
23823158
14.

Outcome of recurrent and persistent disease of malignant ovarian germ cell tumor: a retrospective analysis at King Chulalongkorn Memorial Hospital.

Lertkhachonsuk R, Manchana T, Termrungruanglert W, Vasuratna A, Sittisomwong T, Worasethsin P, Sirisabya N, Khemapech N, Tresukosol D.

J Med Assoc Thai. 2006 Feb;89(2):138-44.

PMID:
16578998
15.

Clinicopathologic characteristics of malignant germ cell tumors in the ovaries of Korean women: a Korean Gynecologic Oncology Group Study.

Lee KH, Lee IH, Kim BG, Nam JH, Kim WK, Kang SB, Ryu SY, Cho CH, Choi HS, Kim KT; Korean Gynecologic Oncology Group.

Int J Gynecol Cancer. 2009 Jan;19(1):84-7. doi: 10.1111/IGC.0b013e31819914c5.

PMID:
19258947
16.

The impact of clinicopathologic and surgical factors on relapse and pregnancy in young patients (≤40 years old) with borderline ovarian tumors.

Fang C, Zhao L, Chen X, Yu A, Xia L, Zhang P.

BMC Cancer. 2018 Nov 21;18(1):1147. doi: 10.1186/s12885-018-4932-2.

17.

Fertility management for malignant ovarian germ cell tumors patients.

Di Tucci C, Casorelli A, Morrocchi E, Palaia I, Muzii L, Panici PB.

Crit Rev Oncol Hematol. 2017 Dec;120:34-42. doi: 10.1016/j.critrevonc.2017.10.005. Epub 2017 Oct 16. Review.

PMID:
29198336
18.

Fertility-Sparing Surgery Should Be the Standard Treatment in Patients with Malignant Ovarian Germ Cell Tumors.

Turkmen O, Karalok A, Basaran D, Kimyon GC, Tasci T, Ureyen I, Tulunay G, Turan T.

J Adolesc Young Adult Oncol. 2017 Jun;6(2):270-276. doi: 10.1089/jayao.2016.0086. Epub 2017 Jan 13.

PMID:
28085535
19.

Outcome and risk factors for recurrence in malignant ovarian germ cell tumors: a MITO-9 retrospective study.

Mangili G, Sigismondi C, Gadducci A, Cormio G, Scollo P, Tateo S, Ferrandina G, Greggi S, Candiani M, Lorusso D.

Int J Gynecol Cancer. 2011 Nov;21(8):1414-21. doi: 10.1097/IGC.0b013e3182236582.

PMID:
21795985
20.

An Analysis of Prognostic Factors in Patients with Ovarian Malignant Germ Cell Tumors Who Are Treated with Fertility-Preserving Surgery.

Yang ZJ, Liu ZC, Wei RJ, Li L.

Gynecol Obstet Invest. 2016;81(1):1-9. doi: 10.1159/000381771. Epub 2015 May 1.

PMID:
25967958

Supplemental Content

Support Center